Methods and compositions for delivering interleukin-1 receptor antagonist
View Patent ↗Methods and compositions generating and using an interleukin-1 receptor antagonist (IL-1ra)-rich solution. Methods for generating and isolating interleukin-1 receptor antagonist include incubating adipose tissue and/or adipocytes with polyacrylamide beads to produce interleukin-1 receptor antagonist. The interleukin-1 receptor antagonist is isolated from the polyacrylamide beads to obtain the solution rich in interleukin-1 receptor antagonist. Methods for treating a site of inflammation in a patient include administering to the site of inflammation the solution rich in interleukin-1 receptor antagonist.
1. A method for generating a solution rich in interleukin-1 receptor antagonist comprising: (a) contacting isolated adipose tissue with polyacrylamide beads, wherein the polyacrylamide beads activate the isolated adipose tissue to produce interleukin-1 receptor antagonist to form a solution rich in interleukin-1 receptor antagonist; and (b) separating the solution rich in interleukin-1 receptor antagonist from the isolated adipose tissue and the polyacrylamide beads.
2. The method for generating a solution rich in interleukin-1 receptor antagonist according to claim 1 , wherein the contacting comprises incubating the isolated adipose tissue with the polyacrylamide beads for a time of from about 30 seconds to about 24 hours.
3. The method for generating a solution rich in interleukin-1 receptor antagonist according to claim 1 , wherein the contacting further comprises contacting a liquid volume comprising white blood cells with the polyacrylamide beads.
4. The method for generating a solution rich in interleukin-1 receptor antagonist according to claim 3 , wherein the liquid volume comprising white blood cells is whole blood, platelet rich plasma, or whole blood and platelet rich plasma.
5. The method for generating a solution rich in interleukin-1 receptor antagonist according to claim 1 , wherein the separating comprises centrifuging the isolated adipose tissue and polyacrylamide beads to obtain a supernatant comprising the solution rich in interleukin-1 receptor antagonist.
6. The method for generating a solution rich in interleukin-1 receptor antagonist according to claim 1 , wherein the solution rich in interleukin-1 receptor antagonist comprises from about 30,000 pg/mL to about 110,000 pg/mL interleukin-1 receptor antagonist.
7. A method for generating a solution rich in interleukin-1 receptor antagonist for treating an inflammatory disorder in a patient, the method comprising: (a) obtaining adipose tissue from the patient; (b) loading the adipose tissue into a concentrator assembly including polyacrylamide beads and incubating the mixture of polyacrylamide beads and adipose tissue to form a solution of interleukin-1 receptor antagonist; and (c) rotating the concentrator assembly at centrifugal speeds to separate the interleukin-1 receptor antagonist from the polyacrylamide beads and adipose tissue to obtain the solution rich in interleukin-1 receptor antagonist.
8. The method for generating a solution rich in interleukin-1 receptor antagonist according to claim 7 , wherein the loading comprises incubating the adipose tissue with the polyacrylamide beads for a time of from about 30 seconds to about 24 hours.
9. The method for generating a solution rich in interleukin-1 receptor antagonist according to claim 7 , wherein the loading further comprises loading a liquid volume comprising white blood cells into the concentrator assembly.
10. The method for generating a solution rich in interleukin-1 receptor antagonist according to claim 9 , wherein the liquid volume comprising white blood cells is whole blood, platelet rich plasma, or whole blood and platelet rich plasma.